Association of CD49d and CD44 in CLL Patients and Their Role in Prognosis
NCT03380299 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2
Last updated 2017-12-21
Summary
The interactions of chronic lymphocytic leukemia cells with the microenvironment in secondary lymphoid tissues and the bone marrow are known to promote CLL cell survival and proliferation
Conditions
- Cellular Diagnosis, Chronic Lymphocytic Leukemia
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-14
- Primary Completion
- 2018-09-14
- Completion
- 2018-12-14
More Related Trials
-
Potential Role of CD9 and Implication of Motility Process in Pathogenesis of TEL/ALM1-positive ALL Relapses (LAL TEL/ALM1 and CD9).
NCT01282593 ·Status: COMPLETED ·Phase: NA
-
LEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION
NCT07313982 ·Status: RECRUITING
-
A Study to Evaluate ICP-022 in Patients With CLL/ SLL
NCT03493217 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study of the Immunological Infiltrate and Immunometabolic Immunometabolic Profile of Patients with Acute Leukaemia
NCT06814444 ·Status: RECRUITING
-
Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis
NCT00481858 ·Status: COMPLETED
-
Zebutinib Combined With Immunochemotherapy in the Treat of Newly Treated CLL Patients Without 17p-/TP53 Mutation
NCT04980859 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of Splenic Irradiation in Chronic Lymphatic Leukemia
NCT02020109 ·Status: WITHDRAWN
-
Cd11b and Cd56 as Prognostic Markers in Acute Myeloid Leukemia
NCT03283228 ·Status: UNKNOWN
-
informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia
NCT02582879 ·Status: COMPLETED
-
Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated Water
NCT01110850 ·Status: COMPLETED
-
A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma
NCT01169298 ·Status: COMPLETED ·Phase: PHASE1
-
Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia
NCT01460238 ·Status: COMPLETED
-
Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier"
NCT00155844 ·Status: UNKNOWN
-
Evaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic Leukemia
NCT03971565 ·Status: UNKNOWN
-
Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based Therapy
NCT01145469 ·Status: COMPLETED
-
Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
NCT00759798 ·Status: COMPLETED ·Phase: PHASE2
-
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
NCT00281918 ·Status: COMPLETED ·Phase: PHASE3
-
Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma
NCT07030400 ·Status: RECRUITING
-
Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient Program
NCT02582320 ·Status: COMPLETED
-
Evaluation of CD47, "Do Not Eat Me" Signal Expression in Chronic Myeloid Leukemia
NCT06865443 ·Status: NOT_YET_RECRUITING
-
French Observational Study of Patients With Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma in Real-World Settings
NCT05590702 ·Status: ACTIVE_NOT_RECRUITING
-
A Prognostic Tool for Early Stage CLL
NCT03436524 ·Status: COMPLETED
-
Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission
NCT00899899 ·Status: COMPLETED
-
Financial Difficulty in Patients With Blood Cancer
NCT05212233 ·Status: COMPLETED
-
Genomic Changes in Childhood Acute Lymphoblastic Leukemia
NCT01089907 ·Status: UNKNOWN